文献速递产科麻醉区域麻醉与超声

接受硬膜外分娩镇痛产妇中IL-1受体拮抗剂基因多态性与产时发热的前瞻性孟德尔随机研究

Interleukin-1 receptor antagonist polymorphisms in women receiving epidural analgesia who develop maternal intrapartum fever: a prospective, multicentre Mendelian randomised study.
PubMed 文献 · Br J Anaesth · 2025-05-14

本研究前瞻性纳入624例接受硬膜外分娩镇痛的产妇,基于rs6743376和rs1542176构建IL-1Ra等位基因评分,比较评分0与≥1组产时发热(>38°C)或使用产时抗生素的复合结局。结果显示两组发生率分别为25.7%与24.7%(OR 1.05,95%CI 0.60-1.83;P=0.89),遗传预测的IL-1Ra水平升高未改变产时发热或抗生素使用发生率。

要点

  • 遗传预测较高的IL-1Ra水平与产时发热或抗生素使用无显著关联。
  • 复合结局发生率在等位基因评分0组为25.7%,≥1组为24.7%。
  • 硬膜外相关产时发热的机制可能不完全由IL-1Ra通路介导。

核心结论

  • 在接受硬膜外分娩镇痛的产妇中,遗传预测较高的IL-1Ra水平不改变产时发热或产时抗生素使用的发生率。

研究设计与样本

  • 前瞻性、多中心孟德尔随机研究,纳入624例≥18岁接受硬膜外分娩镇痛的产妇,排除已有发热、抗生素治疗或免疫缺陷者。
  • 基于rs6743376和rs1542176的C等位基因频率构建IL-1Ra等位基因评分,比较评分0(遗传预测IL-1Ra最低)与≥1组。

主要发现

  • 624例中155例(24.8%)发生母体发热或接受抗生素。
  • 等位基因评分0组74例中19例(25.7%)发生发热或使用抗生素,≥1组550例中136例(24.7%)发生(OR 1.05,95%CI 0.60-1.83;P=0.89)。

临床怎么用

  • 对于接受硬膜外分娩镇痛的产妇,IL-1Ra相关基因多态性不宜作为产时发热风险分层依据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Genetically predicted higher levels of the anti-inflammatory cytokine interleukin-1 receptor antagonist (IL1-Ra) might reduce the risk of developing epidural-related maternal fever, a phenomenon that occurs exclusively in women having epidural analgesia in labour. We hypothesised that in women having epidural analgesia, the absence of specific alleles that lower circulating levels of IL1-Ra would be associated with the development of epidural-related maternal fever, administration of intrapartum antibiotics, or both. METHODS: We prospectively enrolled women ≥18 yr of age receiving epidural analgesia during labour, excluding those with pre-existing fever, antibiotic therapy, or immunodeficiency. Allele scores were constructed from genotyping the C-allele frequency at variants rs6743376 and rs1542176; more copies of each allele independently raise IL-1Ra. The composite primary outcome was maternal intrapartum fever (>38°C) or administration of intrapartum antibiotics after epidural placement. The exposure of interest was the IL1-Ra allele score, comparing 0 (lowest genetically predicted IL-1Ra levels) with ≥1 allele scores. Maternal fever and antibiotic administration were compared in women with 0 or ≥1 allele scores. RESULTS: Of 624 women genotyped, 155 (24.8%) developed maternal fever or received antibiotics. Fever or antibiotic administration occurred in 19/74 (25.7%) labouring women with an IL-1Ra allele score of 0, compared with 136/550 (24.7%) women with IL-1Ra allele scores ≥1 (odds ratio 1.05, 95% confidence interval 0.60-1.83; P=0.89). CONCLUSIONS: In women who receive epidural analgesia during labour, genetically predicted (higher) interleukin-1 receptor antagonist levels do not alter the incidence of maternal intrapartum fever or use of intrapartum antibiotics. CLINICAL TRIAL REGISTRATION: ISRCTN99641204.

来源:Br J Anaesth,查看原文。版权归原作者所有。

引用

  1. Interleukin-1 receptor antagonist polymorphisms in women receiving epidural analgesia who develop maternal intrapartum fever: a prospective, multicentre Mendelian randomised study. Br J Anaesth. 2025. PMID: 40368685. doi:10.1016/j.bja.2025.03.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。